Stay updated on Avelumab Program Rollover Study Clinical Trial
Sign up to get notified when there's something new on the Avelumab Program Rollover Study Clinical Trial page.

Latest updates to the Avelumab Program Rollover Study Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing v3.4.2. This is a metadata/version update and does not reflect a substantive change to the study details.SummaryDifference0.1%

- Check13 days agoChange DetectedThe updates appear to be minor UI/formatting changes with no core study data changed. Core study details like eligibility, endpoints, enrollment, and locations remain intact.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added. The previous government funding notice and Revision: v3.4.1 were removed.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded a funding-status notice about government funding lapse and the NIH Clinical Center's status. Updated the page revision tag from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check48 days agoChange DetectedMinor UI and metadata updates were implemented: a glossary toggle was added and new Last Update fields (Last Update Submitted that Met QC Criteria, Last Update Posted) appeared, along with a revision label (Revision: v3.4.0). The core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. This is a minor version/documentation change that does not affect study data or how the page is used; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Avelumab Program Rollover Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Program Rollover Study Clinical Trial page.